Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,304 warrant series at 1,050 companies. 774 in the money, 59 expiring in the next 30 days, 34 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAD Warrants (expiring February 16, 2028) | $7.88 | $174.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| CAD Warrants (expiring March 15, 2028) | $7.88 | $174.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Initial Debenture Warrants | $7.88 | $174.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| IPO Agent Warrants | $7.88 | $174.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Prefunded warrants (October 2025 public offering) | $7.88 | $174.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Private placements (equity-classified warrants) | $7.88 | $174.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| April 2026 Warrant (ATW Partners, issued in exchange for senior convertible notes) | $1.36 | $174.1M | 6-K, Apr 29, 2026Dilution tabAs of Oct 4, 2026 | ||||||||
| Private Placement Warrants (former RFAC private warrants – Sponsor and EarlyBirdCapital) | $1.36 | $174.1M | 20-F, Jul 31, 2026Dilution tabAs of Oct 4, 2026 | ||||||||
| Public Warrants (former RFAC public warrants, GCLWW) | $1.36 | $174.1M | 20-F, Jul 31, 2026Dilution tabAs of Oct 4, 2026 | ||||||||
| Pre-funded warrants issued in February 2025 underwritten public offering (exercise price $0.001) | $1.16 | $173.9M | 6-K EX-99.1, Nov 3, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Private Placement Warrants | $10.02 | $172.8M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 15, 2026 | ||||||||
| Public Warrants (included in Units sold in the Public Offering) | $10.02 | $172.8M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 15, 2026 | ||||||||
| 2022 Underwriter Warrants – $60.00 strike | $3.35 | $172.7M | 10-Q, Sep 11, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2022 Underwriter Warrants – $61.95 strike | $3.35 | $172.7M | 10-Q, Sep 11, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Asset Manager Warrants | $3.35 | $172.7M | POS AM, Oct 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Pre-funded Warrants (August 2025 PIPE) | $3.35 | $172.7M | POS AM, Oct 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Public Warrants (BNCWW) | $3.35 | $172.7M | POS AM, Oct 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Stapled Warrants (BNCWZ) | $3.35 | $172.7M | POS AM, Oct 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Strategic Advisor Warrants | $3.35 | $172.7M | POS AM, Oct 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| PFG Convertible Warrants (fifth tranche 5A/5B) | $2.00 | $171.8M | 20-F, Apr 13, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| September 2024 follow-on offering common warrants ($0.85) | $1.14 | $171.0M | 20-F, Apr 24, 2026Dilution tabAs of Oct 9, 2026 | ||||||||
| Common stock warrants ($4.13 exercise price, expiring April 15, 2029) | $3.92 | $170.2M | 10-K, Mar 26, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Private Placement Warrants (former CCCM private placement warrants assumed by Silvia, Inc.) | $2.23 | $169.3M | 10-K, Feb 18, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Public Warrants (former CCCM public warrants assumed by Silvia, Inc.) | $2.23 | $169.3M | 424B3, Oct 15, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Investor Warrants (Armistice Capital, January 2023) | $52.41 | $168.5M | 20-F, Mar 19, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| PIPE Warrants (M. Arkin Dermatology Ltd., Affiliate Private Placement) | $52.41 | $168.5M | 20-F, Mar 19, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Apexigen Replacement Warrants ($10.14) | $1.42 | $168.0M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Apexigen Replacement Warrants ($66.67) | $1.42 | $168.0M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Apexigen Replacement Warrants ($8.12) | $1.42 | $168.0M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| July 2026 Warrants (Private Placement Common Warrants) | $1.42 | $168.0M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| October 2026 Pre-Funded Warrants | $1.42 | $168.0M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| October 2026 Warrants (Public Offering Common Warrants) | $1.42 | $168.0M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2026 Exchange pre-funded warrants (Venrock) | $12.25 | $168.0M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| March 2026 PIPE pre-funded warrants | $12.25 | $168.0M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| SVB loan warrant (Legacy Korro, issued January 22, 2021; assumed in the November 2023 merger) | $12.25 | $168.0M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2023 Securities Purchase Agreement common warrants (Common Warrants / Tranche A Warrants) | $1.97 | $166.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2023 Securities Purchase Agreement pre-funded warrants | $1.97 | $166.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2024 Securities Purchase Agreement pre-funded warrants | $1.97 | $166.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2024 Underwritten Offering pre-funded warrants | $1.97 | $166.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 Underwritten Offering pre-funded warrants | $1.97 | $166.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 Warrant Exchange Agreement pre-funded warrant (Exchange Warrant) | $1.97 | $166.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| January 2021 pre-funded warrants | $1.97 | $166.8M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| April 2024 Warrants ($4.48, private placement) | $9.97 | $166.6M | S-1, Feb 4, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| December 2025 Warrants ($23.00, private placement) | $9.97 | $166.6M | 10-K, Jul 29, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| February 2022 Warrants ($8.00) | $9.97 | $166.6M | 424B3, Nov 17, 2025Dilution tabAs of Nov 1, 2026 | ||||||||
| November 2024 Warrants ($9.50, registered direct) | $9.97 | $166.6M | 424B3, Nov 17, 2025Dilution tabAs of Nov 1, 2026 | ||||||||
| 2025 Pre-Funded Warrants (issued in exchange for common stock under the June 2025 Exchange Agreements) | $4.32 | $165.6M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2026 Pre-Funded Warrants (2026 Private Placement, closed March 10, 2026) | $4.32 | $165.6M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Hangzhou Lianluo warrants (April 28, 2016 securities purchase agreement), $352.00 strike | $7.82 | $164.0M | 20-F, Apr 28, 2026Dilution tabAs of Nov 2, 2026 | ||||||||
| Lender common stock warrants (loan and security agreement dated March 8, 2024) | $3.48 | $163.7M | 10-K, Mar 12, 2026Dilution tabAs of Nov 16, 2026 |
ACOGAlpha Cognition Inc$7.88Last price
CAD Warrants (expiring February 16, 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$174.3M
ACOGAlpha Cognition Inc$7.88Last price
CAD Warrants (expiring March 15, 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$174.3M
ACOGAlpha Cognition Inc$7.88Last price
Initial Debenture Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$174.3M
ACOGAlpha Cognition Inc$7.88Last price
IPO Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$174.3M
ACOGAlpha Cognition Inc$7.88Last price
Prefunded warrants (October 2025 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$174.3M
ACOGAlpha Cognition Inc$7.88Last price
Private placements (equity-classified warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$174.3M
GCLGCL Global Holdings Ltd Ordinary Shares$1.36Last price
April 2026 Warrant (ATW Partners, issued in exchange for senior convertible notes)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$174.1M
GCLGCL Global Holdings Ltd Ordinary Shares$1.36Last price
Private Placement Warrants (former RFAC private warrants – Sponsor and EarlyBirdCapital)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$174.1M
GCLGCL Global Holdings Ltd Ordinary Shares$1.36Last price
Public Warrants (former RFAC public warrants, GCLWW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$174.1M
IFRXInflaRx N.V. Common Stock$1.16Last price
Pre-funded warrants issued in February 2025 underwritten public offering (exercise price $0.001)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$173.9M
LTGRLong Table Growth Corp.$10.02Last price
Private Placement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$172.8M
LTGRLong Table Growth Corp.$10.02Last price
Public Warrants (included in Units sold in the Public Offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$172.8M
BNCBNB Standard Corp.$3.35Last price
2022 Underwriter Warrants – $60.00 strike
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$172.7M
BNCBNB Standard Corp.$3.35Last price
2022 Underwriter Warrants – $61.95 strike
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$172.7M
BNCBNB Standard Corp.$3.35Last price
Asset Manager Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$172.7M
BNCBNB Standard Corp.$3.35Last price
Pre-funded Warrants (August 2025 PIPE)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$172.7M
BNCBNB Standard Corp.$3.35Last price
Public Warrants (BNCWW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$172.7M
BNCBNB Standard Corp.$3.35Last price
Stapled Warrants (BNCWZ)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$172.7M
BNCBNB Standard Corp.$3.35Last price
Strategic Advisor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$172.7M
MRTMarti Technologies, Inc.$2.00Last price
PFG Convertible Warrants (fifth tranche 5A/5B)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$171.8M
RYDERyde Group Ltd.$1.14Last price
September 2024 follow-on offering common warrants ($0.85)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$171.0M
ORMPOramed Pharmaceuticals Inc.$3.92Last price
Common stock warrants ($4.13 exercise price, expiring April 15, 2029)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$170.2M
SVIASilvia, Inc.$2.23Last price
Private Placement Warrants (former CCCM private placement warrants assumed by Silvia, Inc.)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$169.3M
SVIASilvia, Inc.$2.23Last price
Public Warrants (former CCCM public warrants assumed by Silvia, Inc.)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$169.3M
SLGLSol-Gel Technologies Ltd. Ordinary Shares$52.41Last price
Investor Warrants (Armistice Capital, January 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$168.5M
SLGLSol-Gel Technologies Ltd. Ordinary Shares$52.41Last price
PIPE Warrants (M. Arkin Dermatology Ltd., Affiliate Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$168.5M
PYXSPyxis Oncology, Inc.$1.42Last price
Apexigen Replacement Warrants ($10.14)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$168.0M
PYXSPyxis Oncology, Inc.$1.42Last price
Apexigen Replacement Warrants ($66.67)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$168.0M
PYXSPyxis Oncology, Inc.$1.42Last price
Apexigen Replacement Warrants ($8.12)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$168.0M
PYXSPyxis Oncology, Inc.$1.42Last price
July 2026 Warrants (Private Placement Common Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$168.0M
PYXSPyxis Oncology, Inc.$1.42Last price
October 2026 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$168.0M
PYXSPyxis Oncology, Inc.$1.42Last price
October 2026 Warrants (Public Offering Common Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$168.0M
KRROKorro Bio, Inc.$12.25Last price
August 2026 Exchange pre-funded warrants (Venrock)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$168.0M
KRROKorro Bio, Inc.$12.25Last price
March 2026 PIPE pre-funded warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$168.0M
KRROKorro Bio, Inc.$12.25Last price
SVB loan warrant (Legacy Korro, issued January 22, 2021; assumed in the November 2023 merger)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$168.0M
ELDNEledon Pharmaceuticals, Inc.$1.97Last price
2023 Securities Purchase Agreement common warrants (Common Warrants / Tranche A Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$166.8M
ELDNEledon Pharmaceuticals, Inc.$1.97Last price
2023 Securities Purchase Agreement pre-funded warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$166.8M
ELDNEledon Pharmaceuticals, Inc.$1.97Last price
2024 Securities Purchase Agreement pre-funded warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$166.8M
ELDNEledon Pharmaceuticals, Inc.$1.97Last price
2024 Underwritten Offering pre-funded warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$166.8M
ELDNEledon Pharmaceuticals, Inc.$1.97Last price
2025 Underwritten Offering pre-funded warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$166.8M
ELDNEledon Pharmaceuticals, Inc.$1.97Last price
2025 Warrant Exchange Agreement pre-funded warrant (Exchange Warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$166.8M
ELDNEledon Pharmaceuticals, Inc.$1.97Last price
January 2021 pre-funded warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$166.8M
USAUU.S. Gold Corp.$9.97Last price
April 2024 Warrants ($4.48, private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$166.6M
USAUU.S. Gold Corp.$9.97Last price
December 2025 Warrants ($23.00, private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$166.6M
USAUU.S. Gold Corp.$9.97Last price
February 2022 Warrants ($8.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$166.6M
USAUU.S. Gold Corp.$9.97Last price
November 2024 Warrants ($9.50, registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$166.6M
ANTXAN2 Therapeutics, Inc.$4.32Last price
2025 Pre-Funded Warrants (issued in exchange for common stock under the June 2025 Exchange Agreements)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$165.6M
ANTXAN2 Therapeutics, Inc.$4.32Last price
2026 Pre-Funded Warrants (2026 Private Placement, closed March 10, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$165.6M
NEGGNewegg Commerce, Inc.$7.82Last price
Hangzhou Lianluo warrants (April 28, 2016 securities purchase agreement), $352.00 strike
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$164.0M
KRMDKORU Medical Systems, Inc.$3.48Last price
Lender common stock warrants (loan and security agreement dated March 8, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$163.7M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,057 dilution snapshots. 4,848 of 5,304 series state an exercise price and 3,365 an expiry date. 68 record when exercise begins; that count grows as companies are re-extracted. 633 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.